Alithia Intelligent Alliance Office

Alithia is a Tokyo-based biotechnology company specializing in AI-driven drug discovery for challenging therapeutic targets. The company utilizes its proprietary Alithia Intelligent Alliance (AIA) platform to integrate computational modeling with high-throughput experimental validation. By focusing on "undruggable" proteins, Alithia aims to accelerate the development of novel small molecule therapeutics in oncology and immunology. The company operates under an alliance-heavy business model, collaborating with academic and industry partners to advance its internal and partnered pipelines. Its approach combines deep learning with structural biology to identify novel binding pockets on previously inaccessible proteins, such as specific transcription factors.